The board today announced the appointment of Lena Åredal as new CEO. Ms Åredal is currently CEO of Permied, a Swedish MedTech company specializing in microcirculation diagnostics, and before that held senior positions at Baxter. Ms Åredal will join by 15 December at the latest, when acting CFO Johanna Norén will return to being CFO. We find the background relevant and appreciate that a permanent CEO is secured to add focus on returning to growth and Combinostics.
LÄS MER
